Your session is about to expire
← Back to Search
Dermal Filler
Facial Filler for Temporal Hollowing
N/A
Waitlist Available
Research Sponsored by Galderma R&D
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial tests how safe and effective a facial filler is in reducing wrinkles and hollows around the temples.
Who is the study for?
This trial is for men and women over the age of 22 who want to treat temple hollowing without a history of facial surgery, migraines, or allergies to hyaluronic acid gels or local anesthetics. Pregnant or breastfeeding individuals cannot participate.
What is being tested?
The study tests Restylane Contour's effectiveness and safety in treating temple hollowing. Participants are randomly assigned to receive the treatment or no treatment, with evaluators blinded to which group they're in.
What are the potential side effects?
Potential side effects may include reactions at the injection site such as redness, swelling, pain, bruising; allergic reactions; and possibly headaches due to sensitivity to ingredients.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Restylane Contour
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Galderma R&DLead Sponsor
300 Previous Clinical Trials
60,238 Total Patients Enrolled
Study DirectorStudy DirectorGalderma R&D
1,270 Previous Clinical Trials
503,748 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I often have severe headaches or migraines.I am allergic to some injectable skin treatments or certain bacterial proteins.I have had facial surgery that might affect the study's safety or results.I plan to get treatment for temple hollowing.I have had cosmetic procedures or implants.I am a man or a woman not pregnant or breastfeeding, aged 22 or older.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger